Processa Pharmaceuticals, Inc. Current Assets
Processa Pharmaceuticals, Inc. (PCSA) had Current Assets of $2.07 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-14
- 2026-06-30: Assets, Current $2.07M.
- 2026-03-31: Assets, Current $1.94M.
- 2025-12-31: Assets, Current $5.67M.
- 2025-09-30: Assets, Current $6.59M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $2.07M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $1.94M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $5.67M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $6.59M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $7.15M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $3.76M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $1.88M 10-K · filed 2026-03-18 | $1.87M 10-K · filed 2025-03-20 |
| 2024-09-30 | $4.84M 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $7.48M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $9.80M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $5.63M 10-K · filed 2025-03-20 | |
| 2023-09-30 | $7.91M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $9.90M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $12.22M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $8.39M 10-K · filed 2024-03-29 | |
| 2022-09-30 | $10.89M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $13.96M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $16.38M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $18.33M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $20.67M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $22.57M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $24.55M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $16.20M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $375.89K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $576.83K 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $356.52K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $1.01M 10-K · filed 2021-03-25 | |
| 2019-09-30 | $725.25K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $989.91K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $1.54M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $2.02M 10-K · filed 2020-03-06 | |
| 2018-09-30 | $2.80M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $3.59M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $1.84M 10-Q · filed 2018-05-21 | |
| 2017-12-31 | $2.95M 10-K/A · filed 2019-04-08 | |
| 2017-09-30 | $80.26K 10-Q · filed 2017-11-20 | |
| 2017-06-30 | $1.95K 10-Q · filed 2017-10-04 | |
| 2017-03-31 | $1.64K 10-Q · filed 2017-10-04 | |
| 2016-12-31 | $2.34M 10-K · filed 2018-04-16 | $3.24K 10-K · filed 2017-09-25 |
| 2016-09-30 | $35.23K 10-Q · filed 2017-09-08 | |
| 2016-06-30 | $43.50K 10-Q · filed 2017-08-30 | |
| 2016-03-31 | $47.34K 10-Q · filed 2017-08-07 | |
| 2015-12-31 | $104.16K 10-K · filed 2017-09-25 | |
| 2015-09-30 | $322.63K 10-Q · filed 2015-12-01 | |
| 2015-06-30 | $479.19K 10-Q · filed 2015-08-19 | |
| 2015-03-31 | $497.15K 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $383.02K 10-K · filed 2017-06-19 | $379.21K 10-K · filed 2015-04-14 |
| 2014-09-30 | $400.57K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $466.03K 10-Q · filed 2014-08-19 | |
| 2014-03-31 | $478.31K 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $514.71K 10-K · filed 2015-04-14 | |
| 2013-09-30 | $1.31M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $937.79K 10-Q/A · filed 2013-09-06 | |
| 2012-12-31 | $1.16M 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |